1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow Exercise Test: new trials by email Literature Review of Exercise Test trials Research Report on Exercise Test
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cladribine With Simultaneous or Delayed Rituximab to Treat Hairy Cell Leukemia Cladribine, Rituximab, BMbx - Hairy Cell Leukemia | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 175 | 2008-10-20 | 2026-08-18 |
Leukemia (1) · Leukemia, Hairy Cell (1) · Neoplasm, Residual (1)
National Cancer Institute (NCI) (1)
United States (1)